Literature DB >> 12475633

Metabolites released by Cryptococcus neoformans var. neoformans and var. gattii differentially affect human neutrophil function.

Lesley Wright1, William Bubb, John Davidson, Rosemary Santangelo, Mark Krockenberger, Uwe Himmelreich, Tania Sorrell.   

Abstract

Differences in the ability of Cryptococcus neoformans var. neoformans (CNVN) and var. gattii (CNVG) to establish localized lesions in the lungs of healthy humans remain unexplained. In this study, CNVG infection in a rat model was characterized by early neutrophil invasion into lung tissue, but phagocytosis of cryptococci was not observed. The chemical composition of non-enzymic components secreted by one strain of each variety (heat-inactivated supernatants from CNVN and CNVG, termed vns and vgs, respectively) were compared, using magnetic resonance spectroscopy. Effects on human neutrophil viability and functions at both pH 5.5 and 7.0 were investigated, as the pH of cryptococcomas was found to be 5.4-5.6 in vivo. The supernatants were similar in composition, although metabolites in vns were generally present in higher concentrations. In addition, vgs contained two novel metabolites-acetoin and dihydroxyacetone. Polyphosphate was observed in cells from both varieties and may be a source of extracellular inorganic phosphate. Superoxide production in the presence of phorbol ester was enhanced by treatment with vns and decreased by vgs. At pH 5.5, vns caused high levels of necrosis in neutrophils, as well as increased adhesion/migration through A549 lung epithelial cell monolayers. Individual supernatant components such as polyols, acetoin, dihydroxyacetone, and gamma-aminobutyric acid exhibited both pro- and anti-inflammatory properties. Overall, we found that vgs was potentially less pro-inflammatory than vns. Inhibition of neutrophil function by products of CNVG may promote survival of extracellular organisms, and local multiplication to form cryptococcomas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12475633     DOI: 10.1016/s1286-4579(02)00024-2

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  29 in total

1.  In vitro antifungal activities of inhibitors of phospholipases from the fungal pathogen Cryptococcus neoformans.

Authors:  Ranjini Ganendren; Fred Widmer; Vatsala Singhal; Christabel Wilson; Tania Sorrell; Lesley Wright
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

2.  Metabolic adaptation in Cryptococcus neoformans during early murine pulmonary infection.

Authors:  Guanggan Hu; Po-Yan Cheng; Anita Sham; John R Perfect; James W Kronstad
Journal:  Mol Microbiol       Date:  2008-07-30       Impact factor: 3.501

3.  Biochemical and kinetic characterization of xylulose 5-phosphate/fructose 6-phosphate phosphoketolase 2 (Xfp2) from Cryptococcus neoformans.

Authors:  Katie Glenn; Cheryl Ingram-Smith; Kerry S Smith
Journal:  Eukaryot Cell       Date:  2014-03-21

Review 4.  Cryptococcus gattii: a resurgent fungal pathogen.

Authors:  Vishnu Chaturvedi; Sudha Chaturvedi
Journal:  Trends Microbiol       Date:  2011-08-29       Impact factor: 17.079

5.  Cryptococcus gattii infection dampens Th1 and Th17 responses by attenuating dendritic cell function and pulmonary chemokine expression in the immunocompetent hosts.

Authors:  Pornpimon Angkasekwinai; Nuntarat Sringkarin; Oratai Supasorn; Madtika Fungkrajai; Yui-Hsi Wang; Methee Chayakulkeeree; Popchai Ngamskulrungroj; Nasikarn Angkasekwinai; Kovit Pattanapanyasat
Journal:  Infect Immun       Date:  2014-06-30       Impact factor: 3.441

6.  A decade of experience: Cryptococcus gattii in British Columbia.

Authors:  Karen H Bartlett; Po-Yan Cheng; Colleen Duncan; Eleni Galanis; Linda Hoang; Sarah Kidd; Min-Kuang Lee; Sally Lester; Laura MacDougall; Sunny Mak; Muhammad Morshed; Marsha Taylor; James Kronstad
Journal:  Mycopathologia       Date:  2011-09-30       Impact factor: 2.574

Review 7.  Cryptococcus gattii infections.

Authors:  Sharon C-A Chen; Wieland Meyer; Tania C Sorrell
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

8.  Biolistic transformation of a fluorescent tagged gene into the opportunistic fungal pathogen Cryptococcus neoformans.

Authors:  Tonya Taylor; Indrani Bose; Taylor Luckie; Kerry Smith
Journal:  J Vis Exp       Date:  2015-03-19       Impact factor: 1.355

9.  SEC14 is a specific requirement for secretion of phospholipase B1 and pathogenicity of Cryptococcus neoformans.

Authors:  Methee Chayakulkeeree; Simon Andrew Johnston; Johanes Bijosono Oei; Sophie Lev; Peter Richard Williamson; Christabel Frewen Wilson; Xiaoming Zuo; Ana Lusia Leal; Marilene Henning Vainstein; Wieland Meyer; Tania Christine Sorrell; Robin Charles May; Julianne Teresa Djordjevic
Journal:  Mol Microbiol       Date:  2011-03-31       Impact factor: 3.501

10.  Cryptococcus gattii isolates from the British Columbia cryptococcosis outbreak induce less protective inflammation in a murine model of infection than Cryptococcus neoformans.

Authors:  Po-Yan Cheng; Anita Sham; James W Kronstad
Journal:  Infect Immun       Date:  2009-07-27       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.